Vyzkoušejte nový nástroj s podporou AI
Summon Research Assistant
BETA
Risk of solid malignancies in bullous pemphigoid: A large‐scale population‐based cohort study
Kridin, Khalaf, Hammers, Christoph M., Ludwig, Ralf J., Cohen, Arnon D.
Published in Journal of dermatology (01.03.2021)
Published in Journal of dermatology (01.03.2021)
Get full text
Journal Article
Human dose-escalation study of PET imaging CD8+ T-cell infiltration in solid malignancies with [68Ga]Ga -NODAGA-SNA006
Wang, Yan, Zheng, Meng, Zhao, Jun, Wang, Chao, Zhao, Shandong, Bian, Yicong, Dai, Na, Zheng, Yushuang, Sang, Shibiao, Guo, Linchuan, Huang, Chenrong, Zhang, Hua, Jiang, Jiwei, Xu, Chun, Zhao, Qi, Han, Jiajun, Xu, Tao, Qin, Songbing, Miao, Liyan
Published in European journal of nuclear medicine and molecular imaging (01.03.2025)
Published in European journal of nuclear medicine and molecular imaging (01.03.2025)
Get full text
Journal Article
Phase I/II, open-label, multiple ascending dose trial of AGEN2034, an anti–PD-1 monoclonal antibody, in advanced solid malignancies: Results of dose escalation in advanced cancer and expansion cohorts in subjects with relapsed/refractory cervical cancer
Drescher, C., Moore, K.N., Liu, J.F., O’Malley, D.M., Wang, E.W., Wang, J.S.-Z., Subbiah, V., Wilky, B.A., Yuan, G., Dupont, C.D., Gonzalez, A.M., Savitsky, D., Coulter, S., Shebanova, O., Dow, E., Ortuzar, W., Buell, J.S., Stein, R.B., Youssoufian, H.
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
546P Phase I study with expansion cohorts to assess the safety, tolerability, and activity of oral paclitaxel (oPac) + encequidar (E) in combination with pembrolizumab (Pem) in subjects with advanced solid malignancies
Ma, W.W., Singh, P., Manochakian, R., Yoon, H., Adjei, A.A., Lou, Y., Cutler, D., Landers, D., Chan, W-K., Zhi, J., Kwan, R.
Published in Annals of oncology (01.09.2021)
Published in Annals of oncology (01.09.2021)
Get full text
Journal Article
741 TWT-101: a first-in-clinic study of CFI-402411, a hematopoietic progenitor Kinase-1 (HPK1) inhibitor, as single agent or combined with pembrolizumab in subjects with advanced solid malignancies
Papadopoulos, Kyriakos P, Laurie, Scott A, Spira, Alexander, Fu, Siqing, Hamilton, Erika, Ma, Brigette, Wang, Judy S, Sharma, Manish, Chu, Quincy, Spreafico, Anna, Bray, Mark R, Chen, Dih-Yih, Roberts-Thomson, Emily, Sidhu, Roger, Hamid, Omid
Published in Journal for immunotherapy of cancer (01.11.2023)
Published in Journal for immunotherapy of cancer (01.11.2023)
Get full text
Journal Article
1158PPhase I/II, open-label, multiple ascending dose trial of AGEN2034, an anti-PD-1 monoclonal antibody, in advanced solid malignancies: Results of dose escalation in advanced cancer and expansion cohorts in subjects with relapsed/refractory cervical cancer
Drescher, C, Moore, K N, Liu, J F, O'Malley, D M, Wang, E W, Wang, J S-Z, Subbiah, V, Wilky, B A, Yuan, G, Dupont, C D, Gonzalez, A M, Savitsky, D, Coulter, S, Shebanova, O, Dow, E, Ortuzar, W, Buell, J S, Stein, R B, Youssoufian, H
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
Intratumoral generation of 2‐fluoroadenine to treat solid malignancies of the head and neck
Behbahani, Turang E., Rosenthal, Eben L., Parker, William B., Sorscher, Eric J.
Published in Head & neck (01.06.2019)
Published in Head & neck (01.06.2019)
Get full text
Journal Article
Validation of In Vivo Nodal Assessment of Solid Malignancies with USPIO-Enhanced MRI: A Workflow Protocol
Driessen, Daphne A. J. J., de Gouw, Didi J. J. M., Stijns, Rutger C. H., Litjens, Geke, Israël, Bas, Philips, Bart W. J., Hermans, John J., Dijkema, Tim, Klarenbeek, Bastiaan R., van der Post, Rachel S., Nagtegaal, Iris D., van Engen-van Grunsven, Adriana C. H., Brosens, Lodewijk A. A., Veltien, Andor, Zámecnik, Patrik, Scheenen, Tom W. J.
Published in Methods and protocols (07.03.2022)
Published in Methods and protocols (07.03.2022)
Get full text
Journal Article
BC3195, a novel ADC targeting CDH3: Preliminary results of a first-in-human phase I study in patients with advanced solid malignancies
Wang, Sheng, Su, Rong, Li, Xu-Feng, Tang, En-Tzu, Wang, Yi-Wei, Hei, Yong-Jiang, Wu, Yi-Long
Published in Journal of clinical oncology (01.06.2024)
Published in Journal of clinical oncology (01.06.2024)
Get full text
Journal Article
750 TWT-101: a first-in-clinic, phase 1/2 study of CFI-402411, a hematopoietic progenitor kinase-1 (HPK1) inhibitor, as a single agent and in combination with pembrolizumab in subjects with advanced solid malignancies
Papadopoulos, Kyriakos, Fu, Siqing, Hamilton, Erika, Spira, Alexander, Scott, Laurie, Wang, Judy, Ma, Brigette, Spreafico, Anna, Sharma, Manish, Chu, Quincy, Bray, Mark, Michelson, Glenn, Chen, Dih-Yih, Nguyen, Linh, Roberts-Thomson, Emily, Hamid, Omid
Published in Journal for immunotherapy of cancer (01.11.2022)
Published in Journal for immunotherapy of cancer (01.11.2022)
Get full text
Journal Article
Conference Proceeding
Abstract B30: A phase 1 open label, dose-escalation trial evaluating the safety and tolerability of EF-022, macrophage activator, in subjects with advanced solid malignancies
Golan, Talia, Berger, Raanan, Ackerstein, Aliza, Raskin, Steve, Lesokhin, Alexander M., Sidransky, David, Levitt, Mark L., Gadassi, Hana, Yogev, Uri, Shahar, Michal
Published in Molecular cancer therapeutics (01.12.2015)
Published in Molecular cancer therapeutics (01.12.2015)
Get full text
Journal Article
Human dose-escalation study of PET imaging CD8+ T-cell infiltration in solid malignancies with 68GaGa -NODAGA-SNA006
Wang, Yan, Zheng, Meng, Zhao, Jun, Wang, Chao, Zhao, Shandong, Bian, Yicong, Dai, Na, Zheng, Yushuang, Sang, Shibiao, Guo, Linchuan, Huang, Chenrong, Zhang, Hua, Jiang, Jiwei, Xu, Chun, Zhao, Qi, Han, Jiajun, Xu, Tao, Qin, Songbing, Miao, Liyan
Published in European journal of nuclear medicine and molecular imaging (10.12.2024)
Published in European journal of nuclear medicine and molecular imaging (10.12.2024)
Get full text
Journal Article
BC3195, a novel ADC targeting cadherin-3 (CDH3): Updated results of a first-in-human phase I study in patients with advanced solid malignancies
Tu, Haiyan, Sun, Yuping, Qin, Tao, Guo, Hai-jun, Wang, Sheng, Zhang, Li-qin, Ye, Xiang-yun, Hei, Yong-Jiang, Wang, Yiwei, Wu, Yi-Long Lung Cancer
Published in Journal of clinical oncology (01.06.2025)
Published in Journal of clinical oncology (01.06.2025)
Get full text
Journal Article
High Levels of Circulating VEGFR2+ Bone Marrow–Derived Progenitor Cells Correlate with Metastatic Disease in Patients with Pediatric Solid Malignancies
Taylor, Melissa, Rössler, Jochen, Geoerger, Birgit, Laplanche, Agnès, Hartmann, Olivier, Vassal, Gilles, Farace, Françoise
Published in Clinical cancer research (15.07.2009)
Published in Clinical cancer research (15.07.2009)
Get full text
Journal Article
Population pharmacokinetics and pharmacodynamics of BYL719, a phosphoinositide 3‐kinase antagonist, in adult patients with advanced solid malignancies
De Buck, Stefan S., Jakab, Annamaria, Boehm, Markus, Bootle, Douglas, Juric, Dejan, Quadt, Cornelia, Goggin, Timothy K.
Published in British journal of clinical pharmacology (01.09.2014)
Published in British journal of clinical pharmacology (01.09.2014)
Get full text
Journal Article